NextCure, Inc.
NXTC
We are a clinical-stage biopharmaceutical company that is focused on advancing innovative medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted therapies, including antibody-drug conjugates ( ADCs ). An ADC consists of a monoclonal antibody conjugated to a cytotoxic drug via a chemical linker.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$41M
▼ -0.3% YoY
Op. Margin
–
ROIC
-140.71%
▼ -32.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$43M
▼ -20.2% YoY
Op. Cash Flow (TTM)
-$43M
▼ -21.6% YoY
Net Debt
-$9M
Net Cash Position
Cash & Equiv.
$9M
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with NXTC
NextCure (NXTC) in three numbers
Questions about NextCure
Is NextCure a high-quality business?
NextCure scores 40 out of 100 on Intrinsiqq's quality score, which makes it a mixed business on these measures. The score blends 6 checks computed from SEC filings. Its best check is revenue growth at 252.6%, and its weakest is return on capital at -140.7%. The Quality tab shows every check against its target.
Does NextCure (NXTC) pay a dividend?
No. NextCure (NXTC) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 9 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in NXTC's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing NXTC
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.